Redesigning drug discovery
Nature 384(6604 Suppl): 1-5
1996
ISSN/ISBN: 0028-0836 PMID: 8895591 Document Number: 461884
Part of a special supplement, sponsored by Glaxo Wellcome, on intelligent drug design. Glaxo Wellcome aims to introduce 3 significant new medicines a year, every year, by 2000. To achieve this objective, drug discovery now involves multidisciplinary teams with members working in parallel. Research is focused on diseases that are clinically relevant and commercially viable, and development disciplines are becoming involved earlier in the overall process of drug design. New technologies are being adopted to achieve major improvements in productivity. In addition, Glaxo Wellcome is promoting partnerships, collaborations, and alliances with other members of the international biomedical research community.